Last reviewed · How we verify
NCT05089747: CIRCAN MAP
CIRculating CANcer MAster-Protocol
trial testing Blood sampling for biomarker analysis (microRNA, circulating DNA…) in Adult With Solid Cancer in 6,000 participants. Currently enrolling.
1 December 2047
Quick facts
| Lead sponsor | Hospices Civils de Lyon |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 6,000 |
| Start date | 5 December 2022 |
| Primary completion | 1 December 2047 |
| Estimated completion | 1 December 2047 |
| Sites | 5 locations across France |
Drugs / interventions tested
- Blood sampling for biomarker analysis (microRNA, circulating DNA…) — full drug profile →
Conditions studied
- Adult With Solid Cancer — all drugs for Adult With Solid Cancer →
Sponsor
Hospices Civils de Lyon — full company profile →
Who can join
18 and older, any sex, with Adult With Solid Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ambivalent roles of miRNAs in cancer development via modulating tumor-associated innate immune cells.
Naseri B, Mardi A, Shekari N, Shajari N, et al · · 2025 · PMID 41409584 · DOI 10.34172/bi.31430
Verify or expand the search:
- PubMed search for NCT05089747
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hospices Civils de Lyon trials
Trials by the same sponsor.
- NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
- NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
- NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
- NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
- NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05089747 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
- Last refreshed: 24 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05089747.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing